Sollis has completed enrolling RePRIEVE CM. Future clinical development studies to be announced.
Under the 21st Century Cures Act, the manufacturer or distributor of one or more investigational drugs for the diagnosis, monitoring, or treatment of one or more serious diseases or conditions shall make available its policy on how it evaluates and responds to requests submitted under section 561(b) of the Federal Food, Drug, and Cosmetic Act for provision of such a drug.
Sollis expanded access policy
The Sollis Clonidine Micropellet is currently not available for use outside Sollis Sponsored Clinical Trials. Please click the following link for information about Sollis Sponsored Clinical Trials: RePRIEVE CM
For more information please contact Sollis Therapeutics at email@example.com.